Halozyme Therapeutics shares owned by Sheaff Brock Investment Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Sheaff Brock Investment Advisors
from 13F filings
Historical chart of Sheaff Brock Investment Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Sheaff Brock Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Sheaff Brock Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $370k | 7.7k | 47.81 |
| 2024-09-30 | $407k | 7.1k | 57.24 |
| 2024-06-30 | $346k | 6.6k | 52.36 |
| 2024-03-31 | $225k | 5.5k | 40.68 |
| 2022-12-31 | $263k | 4.6k | 56.90 |
More positions owned by Sheaff Brock Investment Advisors
View all positions for Sheaff Brock Investment Advisors